Rule 144 notice covers sale of 4031 NYSE common shares

A holder of COR common stock has filed a Rule 144 notice to sell 4031 shares on the NYSE, with an aggregate market value of $1383580.29, out of 193993444 shares of this class outstanding.

Rhea-AI Filing Summary

A holder of COR common stock has filed a Rule 144 notice to sell 4031 shares on the NYSE, with an aggregate market value of $1383580.29, out of 193993444 shares of this class outstanding.

The shares were acquired through restricted stock vesting from the issuer as compensation on four dates in 2025, in amounts of 1375, 1032, 1022, and 602 shares, with payment recorded on the same dates. The planned sale date is approximately December 17, 2025, through Fidelity Brokerage Services LLC. The person signing the notice represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the COR Rule 144 filing disclose?

It discloses that a holder of COR common stock plans to sell 4031 shares on the NYSE under Rule 144.

How many COR shares are planned to be sold and what is their market value?

The notice covers the planned sale of 4031 common shares with an aggregate market value of $1383580.29.

When were the COR shares being sold acquired and how?

The shares were acquired via restricted stock vesting from the issuer as compensation on 09/30/2025, 11/08/2025, 11/09/2025, and 11/20/2025, in blocks of 1375, 1032, 1022, and 602 shares.

When and where are the COR shares expected to be sold?

The approximate sale date is 12/17/2025, and the shares are to be sold on the NYSE through Fidelity Brokerage Services LLC.

How many COR common shares are outstanding according to this notice?

The notice states that there are 193993444 COR common shares outstanding.

What representation does the selling holder make about COR’s information disclosure?

By signing, the person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges the federal criminal consequences of intentional misstatements or omissions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/17/2025 - 03:55 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001627534
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cencora, Inc.
SEC File Number	001-16671
Address of Issuer	1 WEST FIRST AVENUE CONSHOHOCKEN PENNSYLVANIA 19428
Phone	610-727-7000
Name of Person for Whose Account the Securities are To Be Sold	Krikorian Lazarus
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4031	1383580.29	193993444	12/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Restricted Stock Vesting	Issuer			1375	09/30/2025	Compensation
Common	11/08/2025	Restricted Stock Vesting	Issuer			1032	11/08/2025	Compensation
Common	11/09/2025	Restricted Stock Vesting	Issuer			1022	11/09/2025	Compensation
Common	11/20/2025	Restricted Stock Vesting	Issuer			602	11/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lazarus Krikorian
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)